Journey Medical Corporation (DERM)


+0.12 (+4.26%)
Symbol DERM
Price $2.815
Beta 0.000
Volume Avg. 0.15M
Market Cap 51.047M
Shares () -
52 Week Range 1.02-3.19
1y Target Est -
DCF Unlevered DERM DCF ->
DCF Levered DERM LDCF ->
ROE -309.07% Strong Sell
ROA -56.13% Strong Sell
Operating Margin -
Debt / Equity 201920.00% Strong Buy
P/E -1.25 Sell
P/B 10,136.85 Strong Buy


Consensus EPS

Upgrades & Downgrades

Latest DERM news

Mr. Claude Maraoui
Drug Manufacturers—Specialty & Generic
NASDAQ Capital Market

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.